A Pilot Study on Animal-Assisted Intervention in Correctional Settings
Launched by THE UNIVERSITY OF HONG KONG · May 5, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new program that uses animal-assisted intervention (AAI) to help improve the mental health of individuals in correctional facilities. Many people in prisons experience issues like depression, anxiety, and post-traumatic stress, which can make it difficult for them to adjust and succeed after their release. The goal of this study is to see if bringing animals into these settings can provide comfort and support, making it easier for participants to engage in mental health treatment.
To participate in this trial, individuals must be at least 18 years old, currently incarcerated, and able to understand Cantonese. However, those with allergies to dogs, fears of dogs, or a history of aggression towards animals will not be eligible. The study is still in the planning stages and has not started recruiting participants yet. If selected, participants can expect to take part in short sessions involving animals, which may help improve their emotional well-being and support their rehabilitation process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • persons-in-custody
- • aged 18 or older
- • understand Cantonese
- Exclusion Criteria:
- • an allergy, a fear, or a dislike toward dogs
- • a history of aggression toward animals
- • a criminal history involving animals
- • a history of neurodevelopmental disorders
- • active psychosis or mania
- • active suicidality
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported